Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 01/08/19941 min de lecture
Conference on Feasibility of Genetic Technology to Close the HIV Window in Donor Screening; Notice of Public Meeting
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA), Office of the Commissioner, is sponsoring a public meeting to evaluate the feasibility and utility of gene amplification techniques to enhance viral detection in the seronegative ``window'' phase of human immunodeficiency virus (HIV) infection. DATES: The public meeting will be held on Monday, September 26, 1994, 7 a.m. to 4 p.m. through Wednesday, September 28, l994, 12 m.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →